Jan C. Buckner

1993–2024 年に発表

108
論文数
26,185
被引用数
87
h 指数
108
i10 指数

被引用数

Jan C. Buckner の年別被引用数1993 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 17 件1998 年: 被引用 16 件1999 年: 被引用 14 件2000 年: 被引用 27 件2001 年: 被引用 36 件2002 年: 被引用 32 件2003 年: 被引用 74 件2004 年: 被引用 69 件2005 年: 被引用 88 件2006 年: 被引用 145 件2007 年: 被引用 151 件2008 年: 被引用 173 件2009 年: 被引用 198 件2010 年: 被引用 202 件2011 年: 被引用 203 件2012 年: 被引用 190 件2013 年: 被引用 149 件2014 年: 被引用 179 件2015 年: 被引用 232 件2016 年: 被引用 201 件2017 年: 被引用 325 件2018 年: 被引用 230 件2019 年: 被引用 859 件2020 年: 被引用 953 件2021 年: 被引用 781 件2022 年: 被引用 714 件2023 年: 被引用 451 件2024 年: 被引用 663 件2025 年: 被引用 288 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,941 件、この内訳の 31.7%中国: 引用元論文 810 件、この内訳の 8.7%ドイツ: 引用元論文 589 件、この内訳の 6.3%イギリス: 引用元論文 444 件、この内訳の 4.8%イタリア: 引用元論文 413 件、この内訳の 4.5%カナダ: 引用元論文 410 件、この内訳の 4.4%フランス: 引用元論文 378 件、この内訳の 4.1%オランダ: 引用元論文 335 件、この内訳の 3.6%スイス: 引用元論文 273 件、この内訳の 2.9%日本: 引用元論文 238 件、この内訳の 2.6%オーストラリア: 引用元論文 208 件、この内訳の 2.2%スペイン: 引用元論文 189 件、この内訳の 2%
0%31.7%その他 22.2%

分野

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Neuroscience2.6%
  • Immunology and Microbiology2.2%
  • Engineering1.2%
  • Materials Science1.1%
  • その他3.4%

トピック

  • Glioma Diagnosis and Treatment17.9%
  • Brain Metastases and Treatment8.3%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • Meningioma and schwannoma management2.9%
  • Lung Cancer Research Studies1.8%
  • Cancer Genomics and Diagnostics1.6%
  • その他64.3%

共著者

全論文

検索で開く
  1. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

    著者: , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 699

  2. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    著者: , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 1,661

  3. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan M. Chang, Michael D. Prados, Joseph L. Wiemels, John K. Wiencke, Margaret Wrensch, Robert B. Jenkins - New England Journal of Medicine 2015 被引用: 1,984

  4. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 1,192

  5. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 1,044

  6. Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,163

  7. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 68

  8. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco ほか 212 名 - Diabetes Care 2018 被引用: 180

  9. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson ほか 1,520 名 - Diabetes Care 2018 被引用: 169

  10. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

    著者: , , , , , - Journal of Digital Imaging, J. Digit. Imaging 2017 被引用: 201

  11. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 222

  12. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

    著者: , , , , , , , , , , , , , , - Neuro-Oncology 2014 被引用: 166

  13. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

    著者: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 134

  14. Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 357

  15. Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

    著者: , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 186

  16. A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    著者: , , , , , , , , , , , - Cancer Research 2006 被引用: 759

  17. Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 696

  18. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 396

  19. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

    著者: , , , , , , - Neuro-Oncology 2006 被引用: 318

  20. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 被引用: 72

  21. A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

    著者: , , , , , , , , , , , , , - Cancer 2019 被引用: 70

  22. PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme

    著者: , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2001 被引用: 645

  23. Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

    著者: , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 354

  24. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

    著者: , , , , , , , - Medical Physics 2016 被引用: 164